Qlaira is a contraceptive pill that is indicated to prevent pregnancy, since it acts to prevent ovulation from occurring, it alters cervical mucus conditions and also causes changes in the endometrium.
This contraceptive has in its composition 28 tablets of various colors, which correspond to hormones and different hormonal doses.
How to use
The contraceptive Qlaira has a calendar-sticker on the inside with 7 adhesive strips that show the days of the week. The strip corresponding to the day of the beginning of use should be removed and glued in the space indicated for it, so that the day of the week corresponding to the beginning is exactly above the tablet of number 1. Then, the direction of the arrows, until all 28 tablets have been taken. In this way, the person can check if they have taken the contraceptive every day correctly.
The use of the following card must be started the day after the end of the current card, without any pause interval between them and regardless of whether the bleeding has ceased or not.
To start Qlaira correctly, if the person is not using any contraceptives, he should take the first tablet on the first day of the cycle, ie on the first day of menstruation. If you are switching from another combination pill, vaginal ring, or transdermal patch, you should start taking Qlaira the day after the last active tablet in the contraceptive carton you are using is finished. The same is true for the vaginal ring or transdermal patch.
If the person is switching from a mini-pill, the contraceptive Qlaira can be started at any time. In cases of injection, implant or intrauterine system, Qlaira should be started by the date scheduled for the next injection or on the day of removal of the implant or intrauterine system, but it is important to use a condom during the first 9 days of Qlaira use.
Who should not take
Qlaira should not be used in people with a current or previous history of thrombosis, pulmonary embolism or clotting in other parts of the body, current or previous history of a heart attack or stroke, or a particular type of migraine with visual symptoms, difficulty in speech, weakness or numbness in any part of the body.
In addition, it is also contraindicated in people with diabetes mellitus with damage to the vascular system, current or past history of liver disease, cancer that may develop under the influence of sex hormones or liver tumor, unexplained vaginal bleeding, or are pregnant or suspect a pregnancy.
In addition, this medication should not be used in people with an allergy to estradiol valerate, dienogest, or any of the ingredients of Qlaira.
Possible side effects
The most common side effects that can occur with the use of Qlaira are emotional instability, depression, decreased or loss of sexual desire, migraine, nausea, pain in the breasts and unexpected uterine bleeding.
In addition, although very rare, arterial or venous thrombosis may also occur.
